Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Allanore

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Annales De Dermatologie Et De Venereologie|January 22, 2003
[Psoriatic arthritis]Y Allanore
Expert Opinion on Pharmacotherapy|April 22, 2008
Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugsJ Avouac, Y Allanore
Clinical and Experimental Rheumatology|November 6, 2010
Primary myocardial involvement in systemic sclerosis: evidence for a microvascular originY Allanore, C Meune
Annales De Dermatologie Et De Venereologie|June 28, 2006
[Treatment of systemic scleroderma: update]Y Allanore, A Kahan
Clinical and Experimental Rheumatology|October 3, 2009
N-terminal pro brain natriuretic peptide: the new cornerstone of cardiovascular assessment in systemic sclerosisY Allanore, C Meune
Rheumatology (Oxford, England)|September 19, 2006
Primary myocardial involvement in systemic sclerosisA Kahan, Y Allanore
Alimentary Pharmacology & Therapeutics|March 22, 2007
Barrett's oesophagus in systemic sclerosisJ Wipff, Y Allanore
La Revue De Medecine Interne|September 13, 2005
[Spondylarthropathies and anti-TNFalpha drugs]S Pavy, Y Allanore, A Kahan
Autoimmunity Reviews|September 25, 2010
Immunogenetics of systemic sclerosisP Dieudé, C Boileau, Y Allanore
Rheumatology (Oxford, England)|September 17, 2008
Outcome measures for heart involvement in systemic sclerosisY Allanore, C Meune, A Kahan
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Annales De Dermatologie Et De Venereologie|January 22, 2003
[Psoriatic arthritis]Y Allanore
Expert Opinion on Pharmacotherapy|April 22, 2008
Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugsJ Avouac, Y Allanore
Clinical and Experimental Rheumatology|November 6, 2010
Primary myocardial involvement in systemic sclerosis: evidence for a microvascular originY Allanore, C Meune
Annales De Dermatologie Et De Venereologie|June 28, 2006
[Treatment of systemic scleroderma: update]Y Allanore, A Kahan
Clinical and Experimental Rheumatology|October 3, 2009
N-terminal pro brain natriuretic peptide: the new cornerstone of cardiovascular assessment in systemic sclerosisY Allanore, C Meune
Rheumatology (Oxford, England)|September 19, 2006
Primary myocardial involvement in systemic sclerosisA Kahan, Y Allanore
Alimentary Pharmacology & Therapeutics|March 22, 2007
Barrett's oesophagus in systemic sclerosisJ Wipff, Y Allanore
La Revue De Medecine Interne|September 13, 2005
[Spondylarthropathies and anti-TNFalpha drugs]S Pavy, Y Allanore, A Kahan
Autoimmunity Reviews|September 25, 2010
Immunogenetics of systemic sclerosisP Dieudé, C Boileau, Y Allanore
Rheumatology (Oxford, England)|September 17, 2008
Outcome measures for heart involvement in systemic sclerosisY Allanore, C Meune, A Kahan
Pageof 9